You have 9 free searches left this month | for more free features.

Condition

AMN (1)

AMN Gene Mutation (1)

Healthy (1)

X-ALD (1)

X-Linked Adrenoleukodystrophy (1)

Overall Status

Completed (1)

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 1 (1)

Sponsor

NeuroVia, Inc. (1)

Orpheris, Inc. (1)

SwanBio Therapeutics, Inc. (1)

Collaborator

Intervention

imitation procedure (1)

op-101 (1)

sbt101 (1)

sobetirome (nv1205) (1)

Study Documents

Intervention Type

drug (2)

genetic (1)

procedure (1)

Funder Type

Industry (3)

Study Type

Interventional (3)

CCALD

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

AMN, AMN Gene Mutation, X-ALD Trial in Worcester (SBT101, Imitation Procedure)

Recruiting

AMN
+2 more

SBT101
Imitation Procedure

Worcester, Massachusetts

University of Massachusetts Chan Medical School

Jun 1, 2022

X-Linked Adrenoleukodystrophy Trial in Worldwide (Sobetirome (NV1205))

Withdrawn

X-Linked Adrenoleukodystrophy

Sobetirome (NV1205)

Buenos Aires, Argentina
+12 more

Mar 6, 2019

Healthy Trial in Cincinnati (OP-101)

Completed

Healthy

OP-101

Cincinnati, Ohio

Medpace Clinical Pharmacology Unit

Sep 14, 2018